Trial intelligence / Profile preview

ASCOT-2: Stem Cell Ovarian Transplantation for Premature Ovarian Failure

NCT03535480Phase 4Unknown

Sponsor
Health Research Institute Hospital La Fe
Start
Jun 2018
Primary completion
Jun 2020
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 4 trial of autologous bone marrow-derived stem cells in primary ovarian insufficiency (POI), sponsored by Health Research Institute Hospital La Fe. Status: unknown.

02

Drugs

autologous bone marrow-derived stem cells
03

Conditions

primary ovarian insufficiency (POI)

Beyond the preview

Go deeper on NCT03535480.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03535480.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call